share_log

EFFECT: Others

EFFECT: Others

EFFECT:其他
美股SEC公告 ·  04/25 06:05

Moomoo AI 已提取核心訊息

The United States Securities and Exchange Commission (SEC) has declared that 180 Life Sciences Corp.'s submission has become effective as of April 24, 2024. The submission, identified by accession number 0001213900-24-034615 and file number 333-272749, was categorized under the submission type POS AM. This notice of effectiveness by the SEC is a significant step for 180 Life Sciences Corp., indicating that the regulatory body has reviewed and accepted the company's submission.
The United States Securities and Exchange Commission (SEC) has declared that 180 Life Sciences Corp.'s submission has become effective as of April 24, 2024. The submission, identified by accession number 0001213900-24-034615 and file number 333-272749, was categorized under the submission type POS AM. This notice of effectiveness by the SEC is a significant step for 180 Life Sciences Corp., indicating that the regulatory body has reviewed and accepted the company's submission.
美國證券交易委員會(SEC)宣佈,180 Life Sciences Corp. '的提交已於 2024 年 4 月 24 日生效。該提交的材料以入庫號0001213900-24-034615和文件編號333-272749進行識別,歸類爲提交類型 POS AM。美國證券交易委員會發布的這份生效通知對180生命科學公司來說是重要的一步,這表明監管機構已經審查並接受了該公司提交的文件。
美國證券交易委員會(SEC)宣佈,180 Life Sciences Corp. '的提交已於 2024 年 4 月 24 日生效。該提交的材料以入庫號0001213900-24-034615和文件編號333-272749進行識別,歸類爲提交類型 POS AM。美國證券交易委員會發布的這份生效通知對180生命科學公司來說是重要的一步,這表明監管機構已經審查並接受了該公司提交的文件。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息